Literature DB >> 21865886

Immunoelectron microscopic and biochemical studies of caspase-cleaved tau in a mouse model of tauopathy.

Wen-Lang Lin1, Dennis W Dickson, Naruhiko Sahara.   

Abstract

Neurofibrillary tangles (NFTs) have been implicated in mediating neuronal death and disease progression in human tauopathies; however, mounting in vivo data suggest that NFTs may not be the primary initiators of neurotoxicity. Caspase activity has been implicated in processes associated with the development of tauopathy, but the position that caspase activation holds in neurodegenerative cascades remains uncertain. Using multiphoton real-time imaging microscopy, de Calignon et al recently demonstrated that caspase activation precedes and leads to tangle formation within 24 hours in the rTg4510 mouse model of tauopathy. Here, we used immunoelectron microscopy to determine whether caspase-cleaved tau was present in NFTs of rTg4510 mice. Using a caspase-cleaved tau-specific antibody (TauC3), we found very little immunogold labeling in NFTs in the brains of rTg4510 mice. By immunohistochemistry, the number of TauC3-positive neurons was far less than the numbers of neurons stained with the MC1 antibody, which recognizes abnormal conformations of tau. Biochemically, caspase-cleaved tau was barely detectable in fractions of rTg4510 mouse brain extracts. Our data suggest that caspase activation might be one of multiple routes through which NFT formation occurs, rather than an obligatory initiation step in pathologic tau production in rTg4510 mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865886      PMCID: PMC3162471          DOI: 10.1097/NEN.0b013e31822ac9c9

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  28 in total

1.  Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment.

Authors:  R W Berry; A Abraha; S Lagalwar; N LaPointe; T C Gamblin; V L Cryns; L I Binder
Journal:  Biochemistry       Date:  2003-07-15       Impact factor: 3.162

2.  Caspase activation precedes and leads to tangles.

Authors:  Alix de Calignon; Leora M Fox; Rose Pitstick; George A Carlson; Brian J Bacskai; Tara L Spires-Jones; Bradley T Hyman
Journal:  Nature       Date:  2010-03-31       Impact factor: 49.962

3.  Human ICE/CED-3 protease nomenclature.

Authors:  E S Alnemri; D J Livingston; D W Nicholson; G Salvesen; N A Thornberry; W W Wong; J Yuan
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

4.  Caspase-2 mediates neuronal cell death induced by beta-amyloid.

Authors:  C M Troy; S A Rabacchi; W J Friedman; T F Frappier; K Brown; M L Shelanski
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

5.  Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.

Authors:  T Gómez-Isla; R Hollister; H West; S Mui; J H Growdon; R C Petersen; J E Parisi; B T Hyman
Journal:  Ann Neurol       Date:  1997-01       Impact factor: 10.422

6.  Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.

Authors:  T Chris Gamblin; Feng Chen; Angara Zambrano; Aida Abraha; Sarita Lagalwar; Angela L Guillozet; Meiling Lu; Yifan Fu; Francisco Garcia-Sierra; Nichole LaPointe; Richard Miller; Robert W Berry; Lester I Binder; Vincent L Cryns
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-29       Impact factor: 11.205

7.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.

Authors:  Naruhiko Sahara; Miyuki Murayama; Boyoung Lee; Jung-Mi Park; Sarita Lagalwar; Lester I Binder; Akihiko Takashima
Journal:  Eur J Neurosci       Date:  2008-06-06       Impact factor: 3.386

9.  Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.

Authors:  Wen-Lang Lin; Jada Lewis; Shu-Hui Yen; Michael Hutton; Dennis W Dickson
Journal:  J Neurocytol       Date:  2003-11

10.  Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells.

Authors:  Shinji Sato; Yoshitaka Tatebayashi; Takumi Akagi; De-Hua Chui; Miyuki Murayama; Tomohiro Miyasaka; Emmanuel Planel; Kentaro Tanemura; Xiaoyan Sun; Tsutomu Hashikawa; Katsuji Yoshioka; Koichi Ishiguro; Akihiko Takashima
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

View more
  8 in total

1.  Functional implication of β-carotene hydroxylases in soybean nodulation.

Authors:  Yun-Kyoung Kim; Sunghan Kim; Ji-Hyun Um; Kyunga Kim; Sun-Kang Choi; Byung-Hun Um; Suk-Woo Kang; Jee-Woong Kim; Shinichi Takaichi; Seok-Bo Song; Choon-Hwan Lee; Ho-Seung Kim; Ki Woo Kim; Kyoung Hee Nam; Suk-Ha Lee; Yul-Ho Kim; Hyang-Mi Park; Sun-Hwa Ha; Desh Pal S Verma; Choong-Ill Cheon
Journal:  Plant Physiol       Date:  2013-05-22       Impact factor: 8.340

2.  C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins.

Authors:  Yong-Jie Zhang; Tania F Gendron; Jonathan C Grima; Hiroki Sasaguri; Karen Jansen-West; Ya-Fei Xu; Rebecca B Katzman; Jennifer Gass; Melissa E Murray; Mitsuru Shinohara; Wen-Lang Lin; Aliesha Garrett; Jeannette N Stankowski; Lillian Daughrity; Jimei Tong; Emilie A Perkerson; Mei Yue; Jeannie Chew; Monica Castanedes-Casey; Aishe Kurti; Zizhao S Wang; Amanda M Liesinger; Jeremy D Baker; Jie Jiang; Clotilde Lagier-Tourenne; Dieter Edbauer; Don W Cleveland; Rosa Rademakers; Kevin B Boylan; Guojun Bu; Christopher D Link; Chad A Dickey; Jeffrey D Rothstein; Dennis W Dickson; John D Fryer; Leonard Petrucelli
Journal:  Nat Neurosci       Date:  2016-03-21       Impact factor: 24.884

Review 3.  Therapeutic strategies for tau mediated neurodegeneration.

Authors:  Yasumasa Yoshiyama; Virginia M Y Lee; John Q Trojanowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-10-20       Impact factor: 10.154

Review 4.  Tangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing Problem.

Authors:  Kerry L Gendreau; Garth F Hall
Journal:  Front Neurol       Date:  2013-10-21       Impact factor: 4.003

5.  In vitro and in vivo anti-tumor activity of CoQ0 against melanoma cells: inhibition of metastasis and induction of cell-cycle arrest and apoptosis through modulation of Wnt/β-catenin signaling pathways.

Authors:  You-Cheng Hseu; Varadharajan Thiyagarajan; Hsiao-Tung Tsou; Kai-Yuan Lin; Hui-Jye Chen; Chung-Ming Lin; Jiuun-Wang Liao; Hsin-Ling Yang
Journal:  Oncotarget       Date:  2016-04-19

6.  Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits.

Authors:  Anastasia Noël; Bénédicte Foveau; Andréa C LeBlanc
Journal:  Cell Death Dis       Date:  2021-03-01       Impact factor: 8.469

7.  Caspase-mediated truncation of tau potentiates aggregation.

Authors:  Sangmook Lee; Thomas B Shea
Journal:  Int J Alzheimers Dis       Date:  2012-09-04

8.  Co-expression of truncated and full-length tau induces severe neurotoxicity.

Authors:  S Ozcelik; F Sprenger; Z Skachokova; G Fraser; D Abramowski; F Clavaguera; A Probst; S Frank; M Müller; M Staufenbiel; M Goedert; M Tolnay; D T Winkler
Journal:  Mol Psychiatry       Date:  2016-02-02       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.